ArticlePurinergic signalling2026

Tumor-driven purinergic signalling promotes RBFOX1 loss and chemotherapy-induced cardiotoxicity.

Abdel-Aziz S ShatatPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.